Colorectal Cancer - Pipeline Review, H1 2018

  • ID: 4586019
  • Drug Pipelines
  • 2237 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • 3SBio Inc
  • Bayer AG
  • Eli Lilly and Co
  • Ideaya Biosciences Inc
  • Moderna Therapeutics Inc
  • Puretech Health plc
  • MORE
Colorectal Cancer - Pipeline Review, H1 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2018, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason. Risk factors include smoking, heavy alcohol use, inflammatory bowel disease (IBD) and family history. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights:

This latest pipeline guide Colorectal Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 1, 27, 132, 157, 16, 185, 32 and 14 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 1, 23, 9, 1, 30 and 3 molecules, respectively.

Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)
Reasons to buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3SBio Inc
  • Bayer AG
  • Eli Lilly and Co
  • Ideaya Biosciences Inc
  • Moderna Therapeutics Inc
  • Puretech Health plc
  • MORE
Introduction

Colorectal Cancer - Overview

Colorectal Cancer - Therapeutics Development

Colorectal Cancer - Therapeutics Assessment

Colorectal Cancer - Companies Involved in Therapeutics Development

Colorectal Cancer - Drug Profiles

Colorectal Cancer - Dormant Projects

Colorectal Cancer - Discontinued Products

Colorectal Cancer - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Colorectal Cancer, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Products under Development by Companies, H1 2018

Products under Development by Universities/Institutes, H1 2018

Number of Products by Stage and Target, H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018

Number of Products by Stage and Route of Administration, H1 2018

Number of Products by Stage and Molecule Type, H1 2018

Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H1 2018

Colorectal Cancer - Pipeline by 3SBio Inc, H1 2018

Colorectal Cancer - Pipeline by 4SC AG, H1 2018

Colorectal Cancer - Pipeline by AB Science SA, H1 2018

Colorectal Cancer - Pipeline by AbbVie Inc, H1 2018

Colorectal Cancer - Pipeline by AbGenomics International Inc, H1 2018

Colorectal Cancer - Pipeline by Abpro, H1 2018

Colorectal Cancer - Pipeline by Aclaris Therapeutics Inc, H1 2018

Colorectal Cancer - Pipeline by Adamed Sp z oo, H1 2018

Colorectal Cancer - Pipeline by Aduro BioTech Inc, H1 2018

Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H1 2018

Colorectal Cancer - Pipeline by AlfaSigma SpA, H1 2018

Colorectal Cancer - Pipeline by Alligator Bioscience AB, H1 2018

Colorectal Cancer - Pipeline by Allinky Biopharma, H1 2018

Colorectal Cancer - Pipeline by Amarin Corp Plc, H1 2018

Colorectal Cancer - Pipeline by amcure GmbH, H1 2018

Colorectal Cancer - Pipeline by Amgen Inc, H1 2018

Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H1 2018

Colorectal Cancer - Pipeline by APEIRON Biologics AG, H1 2018

Colorectal Cancer - Pipeline by Apexigen Inc, H1 2018

Colorectal Cancer - Pipeline by Aphios Corp, H1 2018

Colorectal Cancer - Pipeline by Aposense Ltd, H1 2018

Colorectal Cancer - Pipeline by Arcus Biosciences Inc, H1 2018

Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H1 2018

Colorectal Cancer - Pipeline by ArQule Inc, H1 2018

Colorectal Cancer - Pipeline by Array BioPharma Inc, H1 2018

Colorectal Cancer - Pipeline by Asana BioSciences LLC, H1 2018

Colorectal Cancer - Pipeline by Ascelia Pharma AB, H1 2018

Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2018

Colorectal Cancer - Pipeline by Astellas Pharma Inc, H1 2018

Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H1 2018

Colorectal Cancer - Pipeline by AstraZeneca Plc, H1 2018

Colorectal Cancer - Pipeline by Aurigene Discovery Technologies Ltd, H1 2018

Colorectal Cancer - Pipeline by Aurobindo Pharma Ltd, H1 2018

Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H1 2018

Colorectal Cancer - Pipeline by B Cell Design SAS, H1 2018

Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H1 2018

Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H1 2018

Colorectal Cancer - Pipeline by Bayer AG, H1 2018

Colorectal Cancer - Pipeline by BeiGene Ltd, H1 2018

Colorectal Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H1 2018

Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H1 2018

Colorectal Cancer - Pipeline by Biocon Ltd, H1 2018

Colorectal Cancer - Pipeline by Bionomics Ltd, H1 2018

Colorectal Cancer - Pipeline by Bionovis SA, H1 2018

Colorectal Cancer - Pipeline by Biotecnol Ltd, H1 2018

Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H1 2018

Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H1 2018

Colorectal Cancer - Pipeline by Boston Biomedical Inc, H1 2018

Colorectal Cancer - Pipeline by Bristol-Myers Squibb Co, H1 2018

Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H1 2018

Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H1 2018

Colorectal Cancer - Pipeline by Cancer Research Technology Ltd, H1 2018

Colorectal Cancer - Pipeline by Cantargia AB, H1 2018

Colorectal Cancer - Pipeline by Carna Biosciences Inc, H1 2018

List of Figures

Number of Products under Development for Colorectal Cancer, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Number of Products by Top 10 Targets, H1 2018

Number of Products by Stage and Top 10 Targets, H1 2018

Number of Products by Top 10 Mechanism of Actions, H1 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Number of Products by Top 10 Routes of Administration, H1 2018

Number of Products by Stage and Top 10 Routes of Administration, H1 2018

Number of Products by Top 10 Molecule Types, H1 2018

Number of Products by Stage and Top 10 Molecule Types, H1
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3-V Biosciences Inc
  • 3SBio Inc
  • 4SC AG
  • AB Science SA
  • AbbVie Inc
  • AbGenomics International Inc
  • Abpro
  • Aclaris Therapeutics Inc
  • Adamed Sp z oo
  • Aduro BioTech Inc
  • Advenchen Laboratories LLC
  • AlfaSigma SpA
  • Alligator Bioscience AB
  • Allinky Biopharma
  • Amarin Corp Plc
  • amcure GmbH
  • Amgen Inc
  • Antibe Therapeutics Inc
  • APEIRON Biologics AG
  • Apexigen Inc
  • Aphios Corp
  • Aposense Ltd
  • Arcus Biosciences Inc
  • ARMO Biosciences Inc
  • ArQule Inc
  • Array BioPharma Inc
  • Asana BioSciences LLC
  • Ascelia Pharma AB
  • Aslan Pharmaceuticals Pte Ltd
  • Astellas Pharma Inc
  • Astex Pharmaceuticals Inc
  • AstraZeneca Plc
  • Aurigene Discovery Technologies Ltd
  • Aurobindo Pharma Ltd
  • AVEO Pharmaceuticals Inc
  • B Cell Design SAS
  • Basilea Pharmaceutica Ltd
  • Bavarian Nordic A/S
  • Bayer AG
  • BeiGene Ltd
  • Beijing Hanmi Pharmaceutical Co Ltd
  • BeyondSpring Pharmaceuticals Inc
  • Biocon Ltd
  • Bionomics Ltd
  • Bionovis SA
  • Biotecnol Ltd
  • Biothera Pharmaceutical Inc
  • Boehringer Ingelheim GmbH
  • Boston Biomedical Inc
  • Bristol-Myers Squibb Co
  • Calithera Biosciences Inc
  • Cancer Prevention Pharmaceuticals Inc
  • Cancer Research Technology Ltd
  • Cantargia AB
  • Carna Biosciences Inc
  • CaroGen Corp
  • CBT Pharmaceuticals Inc
  • CCRP Therapeutics GmbH
  • Celgene Corp
  • Celldex Therapeutics Inc
  • Cellectar Biosciences Inc
  • Celleron Therapeutics Ltd
  • Cellestia Biotech AG
  • Cellix Bio Pvt Ltd
  • Celltrion Inc
  • Celyad SA
  • Checkmate Pharmaceuticals Inc
  • Chipscreen Biosciences Ltd
  • ChoDang Pharm Co Ltd
  • Chong Kun Dang Pharmaceutical Corp
  • Cinnagen Co
  • Cleveland BioLabs Inc
  • COARE Biotechnology Inc
  • Coherus BioSciences Inc
  • Compugen Ltd
  • Conatus Pharmaceuticals Inc
  • Corvus Pharmaceuticals Inc
  • Cotinga Pharmaceuticals Inc
  • CrystalGenomics Inc
  • Daiichi Sankyo Co Ltd
  • DanDrit Biotech A/S
  • Deciphera Pharmaceuticals LLC
  • Dr. Reddy's Laboratories Ltd
  • eFFECTOR Therapeutics Inc
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Endor Nanotechnologies SL
  • EntreChem SL
  • Enzene Biosciences Ltd
  • Enzo Biochem Inc
  • EpiThany Inc
  • Etubics Corp
  • Exelixis Inc
  • Exicure Inc
  • F-star Biotechnology Ltd
  • F. Hoffmann-La Roche Ltd
  • Fate Therapeutics Inc
  • Formation Biologics Inc
  • Formosa Laboratories Inc
  • Forty Seven Inc
  • Fresenius SE & Co KGaA
  • Fujifilm Holdings Corporation
  • Fusion Antibodies Ltd
  • GamaMabs Pharma SA
  • GC Pharma
  • Gene Techno Science Co Ltd
  • Genentech Inc
  • Genmab A/S
  • Genoscience Pharma
  • Genzyme Corp
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Glycostem Therapeutics BV
  • Glycotope GmbH
  • Handok Inc
  • Hanmi Pharmaceuticals Co Ltd
  • Harbin Gloria Pharmaceuticals Co Ltd
  • Heat Biologics Inc
  • Heidelberg Pharma AG
  • Hemispherx Biopharma Inc
  • Hercules Pharmaceuticals BV
  • Humanigen Inc
  • Hutchison MediPharma Ltd
  • iDD biotech SAS
  • Ideaya Biosciences Inc
  • Idera Pharmaceuticals Inc
  • Ignyta Inc
  • Ildong Pharmaceutical Co Ltd
  • Immodulon Therapeutics Ltd
  • Immunomedics Inc
  • Immunovative Therapies Ltd
  • Incanthera Ltd
  • Incyte Corp
  • Innate Pharma SA
  • Innovent Biologics Inc
  • Inovio Pharmaceuticals Inc
  • Interprotein Corp
  • Intezyne Technologies Inc
  • Ipsen SA
  • Isofol Medical AB
  • Jeil Pharmaceutical Co Ltd
  • JHL Biotech Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Johnson & Johnson
  • Karyopharm Therapeutics Inc
  • Kazia Therapeutics Ltd
  • Kura Oncology Inc
  • Laboratorio ELEA SACIF y A
  • LipoMedix Pharmaceutical Inc
  • Loxo Oncology Inc
  • Luye Pharma Group Ltd
  • Mabion SA
  • mAbxience SA
  • MacroGenics Inc
  • Mantis Therapeutics BV
  • Marina Biotech Inc
  • Medesis Pharma SA
  • MediaPharma SRL
  • MediciNova Inc
  • MedImmune LLC
  • Medivir AB
  • MELEMA Pharma GmbH
  • Merck & Co Inc
  • Merck KGaA
  • Merus NV
  • MetaMax Ltd
  • Millennium Pharmaceuticals Inc
  • Mirati Therapeutics Inc
  • Moderna Therapeutics Inc
  • Molecular Partners AG
  • Molecular Templates Inc
  • Mologen AG
  • Morphotek Inc
  • Multimmune GmbH
  • Mycenax Biotech Inc
  • NantKwest Inc
  • Natco Pharma Ltd
  • NatureWise Biotech & Medicals Corp
  • Nektar Therapeutics
  • Neovacs SA
  • Nerviano Medical Sciences Srl
  • Nippon Kayaku Co Ltd
  • NormOxys Inc
  • Northwest Biotherapeutics Inc
  • Novartis AG
  • Noxxon Pharma AG
  • NuCana Plc
  • OBI Pharma Inc
  • Omnitura Therapeutics Inc
  • Oncology Research International Ltd
  • Oncolytics Biotech Inc
  • OncoMed Pharmaceuticals Inc
  • Onconova Therapeutics Inc
  • Ono Pharmaceutical Co Ltd
  • Otsuka Holdings Co Ltd
  • Oxford BioTherapeutics Ltd
  • PDS Biotechnology Corp
  • Pfizer Inc
  • Pharma Mar SA
  • PharmAbcine Inc
  • Pivotal BioSciences Inc
  • PlantForm Corp
  • Plexxikon Inc
  • Polaris Pharmaceuticals Inc
  • Precision Biologics Inc
  • Propanc Biopharma Inc
  • Protheragen Inc
  • Provectus Biopharmaceuticals Inc
  • PsiOxus Therapeutics Ltd
  • Puma Biotechnology Inc
  • Puretech Health plc
  • R Pharm
  • Rafael Pharmaceuticals Inc
  • RedHill Biopharma Ltd
  • Redx Pharma Plc
  • Regeneron Pharmaceuticals Inc
  • Rexahn Pharmaceuticals Inc
  • Rgenix Inc
  • Rhizen Pharmaceuticals SA
  • Richter Gedeon Nyrt
  • Samumed LLC
  • Sanofi
  • Scancell Holdings Plc
  • Seattle Genetics Inc
  • Second Genome Inc
  • Selvita SA
  • Shanghai Henlius Biotech Co Ltd
  • Siamab Therapeutics Inc
  • Sichuan Kelun Pharmaceutical Co Ltd
  • Sierra Oncology Inc
  • Sillajen Biotherapeutics
  • Simcere Pharmaceutical Group
  • Sino Biopharmaceutical Ltd
  • Sorrento Therapeutics Inc
  • ST Pharm Co., Ltd.
  • Steba Biotech SA
  • Sublimity Therapeutics Ltd
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun Pharma Advanced Research Company Ltd
  • SuviCa Inc
  • Symphogen A/S
  • Syndax Pharmaceuticals Inc
  • SynDevRx Inc
  • Synermore Biologics Co Ltd
  • Taiho Pharmaceutical Co Ltd
  • TaiwanJ Pharmaceuticals Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Targovax ASA
  • Tarrex Biopharma Ltd
  • Tarveda Therapeutics Inc
  • Theralase Technologies Inc
  • Tocagen Inc
  • Tolero Pharmaceuticals Inc
  • TRACON Pharmaceuticals Inc
  • Trovagene Inc
  • United BioPharma Inc
  • Vaccinex Inc
  • VasGene Therapeutics Inc
  • Vaximm AG
  • Vincogen Corp
  • Vitality Biopharma Inc
  • WntResearch AB
  • Wuhan YZY Biopharma Co Ltd
  • XBiotech Inc
  • Xencor Inc
  • XuanZhu Pharma Co Ltd
  • Zelluna Immunotherapy AS
  • Zymeworks Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll